-
Mashup Score: 3Disparities and Underutilization of Aggressive Therapy in Muscle-Invasive Bladder Cancer: An NCDB Analysis - James Ferguson - 11 hour(s) ago
Sam Chang is joined by James (Jed) Ferguson to explore disparities in the treatment of muscle-invasive bladder cancer. Dr. Ferguson’s team delved into the National Cancer Database, revealing that a significant percentage of patients do not receive aggressive treatments post-TURBT, with factors such as age, comorbidity, race, insurance status, and treatment facility type playing crucial roles in…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Immunotherapy Improves Survival in Metastatic Bladder Cancer - 1 day(s) ago
Treatment with immune checkpoint inhibitors has improved survival outcomes for patients with metastatic bladder cancer, compared with chemotherapy.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 1
A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 45Seattle, WA: Petros Grivas - Bladder Cancer Advocacy Network - 5 day(s) ago
Contact Us: 4520 East West Highway, Suite 610 Bethesda, Maryland 20814 Phone: (301) 215-9099 Fax: (973) 215-9092 info@bcan.org © 2024 Bladder Cancer Advocacy Network. All Rights
Source: secure2.convio.netCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Monique Oude Elberink on LinkedIn: Home - 8 day(s) ago
Webinar ‘Real-World Data in Advanced Bladder Cancer’. Register now to follow the discussion!
Source: www.linkedin.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 24Plasmacytoid Variant Bladder Cancer: Aggressive Disease Requiring Multimodal Therapy - Akshay Sood - 8 day(s) ago
Ashish Kamat converses with Akshay Sood about the challenging diagnosis and management of non-metastatic plasmacytoid bladder cancer. Dr. Sood elaborates on his comprehensive study published in the Journal of Urology. He highlights the rarity and lethal nature of the plasmacytoid variant, which represents approximately 1% of muscle-invasive bladder cancers. Through a retrospective analysis of 56…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0
The FDA approved nogapendekin alfa inbakicept-pmln plus Bacillus Calmette-Guerin for the treatment of certain patients with bladder cancer, according to a press release from the manufacturer.The indication applies to individuals with Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ.
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
The survival benefit observed with Padcev plus Keytruda was “unlike anything we’d seen before” for advanced bladder cancer, according to an expert.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 38ctDNA and bladder cancer: Current understanding and beyond - 13 day(s) ago
Urologist James Catto asks oncologist Thomas Powles key questions on the role of ctDNA in the understanding of urothelial cancer and its potential to
Source: www.springermedicine.comCategories: General Medicine News, Onc News and JournalsTweet-
ctDNA🧬and #BladderCancer: Current Understanding and Beyond Expert Commentary by our @OncoAlert 🚨faculty @tompowles1 🇬🇧 & Dr. James Catto 🇬🇧 Link: https://t.co/eV8Gu5FYrH Out by our Collaborators at @springer_med Pinging OncoAlert GU Faculty: @montypal @crisbergerot… https://t.co/gSTEeodFmb https://t.co/bvR90Tm0ac
-
-
Mashup Score: 6Empowering Bladder Cancer Care: A Formal Partnership between IBCG and UroToday in the Era of Expanding Therapies - 15 day(s) ago
The International Bladder Cancer Group (IBCG) and UroToday, optimizing bladder cancer patient care, AUA-IBCG Bladder Cancer Forum, bladder cancer education, enfortumab vedotin-ejfv in combination with pembrolizumab.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
Disparities and underutilization of aggressive therapy in muscle-invasive #BladderCancer: an NCDB analysis. James Ferguson @UABUrology and @UroCancerMD discuss factors attributing to variance in care, and what can be done to address these issues > https://t.co/uXdwYglzpG https://t.co/3bRUGSwml0